+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Group Typing Market by Test Type, Technology, Sample Type, Automation Level, Application, End User - Global Forecast 2026-2032- Product Image
Blood Group Typing Market by Test Type, Technology, Sample Type, Automation Level, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Blood Group Typing Market by Test Type, Technology, Sample Type, Automation Level, Application, End User - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989627
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Group Typing Market is projected to reach USD 2.74 Billion in 2026. It is expected to continue growing at a CAGR of 8.26%, reaching USD 4.42 Billion by 2032.

Blood group typing is a core pillar of transfusion medicine, transplant compatibility, prenatal care, and emergency response. The market spans ABO and Rh typing, extended antigen phenotyping, antibody screening, crossmatching, molecular blood group genotyping, reagents, gel cards, microplates, analyzers, and laboratory information connectivity.

Demand is supported by the scale of global blood collection and the clinical requirement to prevent hemolytic transfusion reactions. The World Health Organization reports approximately 118.5 million blood donations worldwide, with high-income countries collecting a disproportionate share relative to population. This uneven distribution is driving investment in safer, faster, and more standardized blood bank diagnostics across both mature and emerging healthcare systems.

Transformative Shifts in the Blood Group Typing Landscape

The blood group typing landscape is shifting from manual tube testing toward automated immunohematology platforms, gel column agglutination, solid-phase methods, and molecular assays. Hospitals and reference laboratories are prioritizing workflows that reduce subjective interpretation, improve traceability, and support high-throughput donor and patient testing.

Regulatory and clinical expectations are also becoming more rigorous. The European Union In Vitro Diagnostic Regulation, FDA oversight of transfusion-related diagnostics, and accreditation frameworks from organizations such as AABB reinforce the need for validated assays, quality controls, and documented performance. These shifts favor suppliers that can combine reliable reagents, automation, informatics, and service support.

Cumulative Impact of Artificial Intelligence in Blood Group Typing

Artificial intelligence is increasingly relevant to blood group typing through image recognition, automated reaction grading, anomaly detection, inventory optimization, and decision support. AI-enabled tools can help laboratories flag discrepant results, prioritize complex antibody investigations, and reduce variability in interpretation when paired with validated quality systems.

The cumulative impact is not replacement of laboratory professionals but augmentation of high-volume and high-risk workflows. AI can strengthen donor-recipient matching by integrating phenotype, genotype, antibody history, and inventory data. Adoption will depend on explainable algorithms, cybersecurity, auditability, regulatory validation, and seamless integration with blood bank information systems.

Key Regional Insights for Blood Group Typing

Asia-Pacific is becoming a major growth engine as China, India, Japan, South Korea, Australia, and ASEAN markets expand hospital capacity, blood bank modernization, and molecular diagnostics adoption. Large patient populations, rising surgical volumes, increasing chronic disease care, and national blood safety initiatives create sustained demand for ABO/Rh typing, antibody screening, crossmatching, and scalable automation.

North America remains highly advanced due to strong hospital networks, established blood collection systems, reference laboratories, patient blood management programs, and rigorous transfusion standards. Europe benefits from mature immunohematology infrastructure, hemovigilance systems, and IVDR-driven quality expectations. Latin America is improving access through public and private investment, with Brazil and Mexico supporting broader modernization of blood bank diagnostics. The Middle East is building premium hospital systems and centralized testing capacity, particularly across high-investment healthcare hubs. Africa presents the greatest unmet need, where WHO data showing lower donation rates in low-income settings underscores the importance of affordable, robust, and decentralized blood group testing.

Key Group Insights Across Strategic Blood Typing Markets

ASEAN countries are advancing blood safety through healthcare infrastructure investment, but adoption varies between urban tertiary centers and resource-constrained facilities. The GCC is characterized by high per-capita health spending, growing specialty care, medical tourism, and demand for automated transfusion diagnostics that support large hospital networks and centralized laboratory models.

The European Union is shaped by IVDR compliance, cross-border quality expectations, hemovigilance, and strong reference laboratory networks. BRICS countries combine high population scale with expanding diagnostic manufacturing, public health programs, and rising demand for standardized blood bank testing. G7 markets emphasize innovation, automation, data connectivity, molecular immunohematology, and patient blood management, while NATO countries increasingly view resilient blood supply chains and interoperable transfusion systems as part of healthcare readiness and emergency preparedness.

Key Country Insights in Blood Group Typing

The United States leads in advanced transfusion diagnostics, reference testing, molecular blood group genotyping, and blood bank automation, while Canada emphasizes standardized quality, donor safety, and national blood service coordination. Mexico and Brazil are expanding access to modern immunohematology testing as private hospitals and public systems upgrade blood safety capabilities and laboratory infrastructure.

The United Kingdom, Germany, France, Italy, and Spain maintain mature blood service models supported by quality systems, hemovigilance, and hospital transfusion governance, with Germany and France notable for strong diagnostic manufacturing and laboratory standards. Russia has a large hospital network with continued demand for standardized and scalable testing. China and India are high-scale opportunities driven by population size, surgery volumes, maternal health needs, trauma care, and blood safety modernization. Japan, South Korea, and Australia combine advanced healthcare systems with strong adoption of automation, molecular methods, reference laboratory expertise, and quality-assured transfusion practices.

Actionable Recommendations for Blood Group Typing Leaders

Industry leaders should prioritize platforms that combine ABO/Rh typing, antibody screening, crossmatching, extended phenotyping, and molecular genotyping within connected workflows. Differentiation will come from reducing turnaround time, minimizing manual interpretation, improving result traceability, and supporting regulation-ready documentation.

Organizations should build region-specific portfolios: high-throughput automation for mature markets, modular and cost-effective systems for emerging markets, and reference-lab solutions for complex antibody and rare donor cases. Partnerships with hospitals, blood services, and informatics vendors can accelerate adoption. Leaders should also invest in AI validation, cybersecurity, reagent supply resilience, staff training, quality control, and post-market surveillance to strengthen trust.

Research Methodology

This executive summary is grounded in secondary research from authoritative sources, including WHO blood safety data, regulatory guidance from the FDA and European Commission, transfusion medicine standards, peer-reviewed immunohematology literature, hemovigilance resources, and public information from blood services and diagnostic manufacturers.

The analysis synthesizes market drivers, technology adoption, regional healthcare capacity, regulatory frameworks, and operational needs across hospitals, donor centers, reference laboratories, and emergency care settings. Insights are presented qualitatively to avoid unsupported market-size claims and to focus on verified trends shaping the blood group typing market. Conclusion

The blood group typing market is entering a more automated, connected, and quality-focused phase. Core ABO/Rh testing remains essential, but growth is increasingly linked to extended antigen matching, molecular genotyping, AI-supported interpretation, rare donor identification, and integrated blood bank informatics.

Organizations that deliver validated accuracy, workflow efficiency, regulatory readiness, data security, and regional affordability will be best positioned. As surgical volumes, chronic disease care, trauma response, transplantation, and maternal health needs continue to drive transfusion demand, reliable blood group typing will remain central to patient safety and health system resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Group Typing Market, by Test Type
7.1. ABO Typing
7.2. Rh Typing
7.3. Antibody Screening
7.4. Antibody Identification
7.5. Antigen Phenotyping
7.6. Crossmatching
8. Blood Group Typing Market, by Technology
8.1. Flow Cytometry
8.2. Gel Centrifugation
8.3. Microplate Agglutination
8.4. PCR
8.4.1. Digital PCR
8.4.2. Real-Time PCR
9. Blood Group Typing Market, by Sample Type
9.1. Whole Blood
9.2. Red Cell Suspension
9.3. Serum Or Plasma
9.4. Buccal Swab
10. Blood Group Typing Market, by Automation Level
10.1. Manual Testing
10.2. Semi-Automated Testing
10.3. Fully Automated Testing
11. Blood Group Typing Market, by Application
11.1. Donor Screening
11.1.1. Blood Typing
11.1.2. Infectious Disease Screening
11.2. Newborn Screening
11.3. Pretransfusion Testing
12. Blood Group Typing Market, by End User
12.1. Blood Banks
12.1.1. Government Blood Banks
12.1.2. Private Blood Banks
12.2. Clinical Laboratories
12.3. Hospitals & Diagnostic Centers
13. Asia-Pacific Blood Group Typing Market
14. Europe Blood Group Typing Market
15. North America Blood Group Typing Market
16. Latin America Blood Group Typing Market
17. Africa Blood Group Typing Market
18. Middle East Blood Group Typing Market
19. NATO Blood Group Typing Market
20. G7 Blood Group Typing Market
21. BRICS Blood Group Typing Market
22. European Union Blood Group Typing Market
23. ASEAN Blood Group Typing Market
24. GCC Blood Group Typing Market
25. China Blood Group Typing Market
26. United States Blood Group Typing Market
27. Japan Blood Group Typing Market
28. India Blood Group Typing Market
29. Germany Blood Group Typing Market
30. United Kingdom Blood Group Typing Market
31. Australia Blood Group Typing Market
32. France Blood Group Typing Market
33. South Korea Blood Group Typing Market
34. Italy Blood Group Typing Market
35. Canada Blood Group Typing Market
36. Russia Blood Group Typing Market
37. Brazil Blood Group Typing Market
38. Mexico Blood Group Typing Market
39. Spain Blood Group Typing Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Agena Bioscience, Inc.
41.3. BAG Diagnostics GmbH
41.4. Beckman Coulter, Inc.
41.5. Bio-Rad Laboratories, Inc.
41.6. CareDx, Inc.
41.7. DIAGAST
41.8. DiaSorin S.p.A.
41.9. F. Hoffmann-La Roche Ltd
41.10. Fujirebio Holdings, Inc.
41.11. Grifols, S.A.
41.12. Hemo Bioscience, Inc.
41.13. Hologic, Inc.
41.14. Illumina, Inc.
41.15. Immucor, Inc.
41.16. Inno-Train Diagnostik GmbH
41.17. Lorne Laboratories
41.18. Merck KGaA
41.19. Novacyt Group
41.20. Ortho Clinical Diagnostics, Inc.
41.21. Precision BioLogic Inc.
41.22. Quotient Limited
41.23. Rapid Labs Ltd.
41.24. Siemens Healthineers AG
41.25. Sysmex Corporation
41.26. Thermo Fisher Scientific Inc.
41.27. Tulip Diagnostics (P) Ltd.
List of Figures
FIGURE 1. GLOBAL BLOOD GROUP TYPING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD GROUP TYPING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD GROUP TYPING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. CHINA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. INDIA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. GERMANY BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. FRANCE BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. ITALY BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CANADA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ABO TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ABO TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ABO TYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RH TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RH TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RH TYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIBODY SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIBODY SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIBODY SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIBODY IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIBODY IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIBODY IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIGEN PHENOTYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTIGEN PHENOTYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTIGEN PHENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CROSSMATCHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CROSSMATCHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CROSSMATCHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GEL CENTRIFUGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GEL CENTRIFUGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GEL CENTRIFUGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MICROPLATE AGGLUTINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MICROPLATE AGGLUTINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MICROPLATE AGGLUTINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RED CELL SUSPENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RED CELL SUSPENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RED CELL SUSPENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SERUM OR PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SERUM OR PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SERUM OR PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BUCCAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BUCCAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BUCCAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MANUAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MANUAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MANUAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SEMI-AUTOMATED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SEMI-AUTOMATED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SEMI-AUTOMATED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FULLY AUTOMATED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FULLY AUTOMATED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FULLY AUTOMATED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DONOR SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DONOR SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DONOR SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BLOOD TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD TYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INFECTIOUS DISEASE SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INFECTIOUS DISEASE SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL INFECTIOUS DISEASE SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEWBORN SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PRETRANSFUSION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PRETRANSFUSION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PRETRANSFUSION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GOVERNMENT BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GOVERNMENT BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GOVERNMENT BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PRIVATE BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PRIVATE BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PRIVATE BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 115. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 117. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 119. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 145. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 147. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 149. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AFRICA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 161. NATO BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. NATO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. NATO BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 165. NATO BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 166. NATO BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 167. NATO BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. NATO BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 169. NATO BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. NATO BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 171. G7 BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. G7 BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 173. G7 BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. G7 BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 175. G7 BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. G7 BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 177. G7 BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. G7 BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 179. G7 BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. G7 BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 181. BRICS BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. BRICS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 183. BRICS BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. BRICS BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 185. BRICS BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 186. BRICS BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 187. BRICS BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. BRICS BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 189. BRICS BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. BRICS BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 201. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 205. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 207. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 209. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. ASEAN BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 211. GCC BLOOD GROUP TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. GCC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 213. GCC BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. GCC BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 215. GCC BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 216. GCC BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 217. GCC BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. GCC BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 219. GCC BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. GCC BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 221. CHINA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 222. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 223. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 225. CHINA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 226. CHINA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 227. CHINA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. CHINA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 229. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. CHINA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 241. JAPAN BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 243. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 245. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 246. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 247. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 249. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 251. INDIA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 253. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 255. INDIA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 256. INDIA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 257. INDIA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. INDIA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 259. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. INDIA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 261. GERMANY BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 263. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 265. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 266. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 267. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 269. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 281. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 282. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 283. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 285. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 286. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 287. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 289. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 291. FRANCE BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 292. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 293. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 294. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 295. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 296. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 297. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 299. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 301. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 302. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 303. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 304. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 305. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 306. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 307. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 308. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 309. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 310. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 311. ITALY BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 312. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 313. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 314. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 315. ITALY BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 316. ITALY BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 317. ITALY BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 318. ITALY BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 319. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. ITALY BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 321. CANADA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 322. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 323. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 324. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 325. CANADA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 326. CANADA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 327. CANADA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 328. CANADA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 329. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 330. CANADA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 331. RUSSIA BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 332. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 333. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 334. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 335. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 336. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 337. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 338. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 339. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 340. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 341. BRAZIL BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 342. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 343. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 344. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 345. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 346. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 347. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 348. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 349. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 350. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 351. MEXICO BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 352. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 353. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 354. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 355. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 356. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 357. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 358. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 359. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 360. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 361. SPAIN BLOOD GROUP TYPING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 362. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 363. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 364. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 365. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 366. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 367. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 368. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY DONOR SCREENING, 2018-2032 (USD MILLION)
TABLE 369. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 370. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Blood Group Typing market report include:
  • Abbott Laboratories
  • Agena Bioscience, Inc.
  • BAG Diagnostics GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • DIAGAST
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Fujirebio Holdings, Inc.
  • Grifols, S.A.
  • Hemo Bioscience, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Inno-Train Diagnostik GmbH
  • Lorne Laboratories
  • Merck KGaA
  • Novacyt Group
  • Ortho Clinical Diagnostics, Inc.
  • Precision BioLogic Inc.
  • Quotient Limited
  • Rapid Labs Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics (P) Ltd.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.74 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.42 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Blood Group Typing - Global Strategic Business Report - Product Image

Blood Group Typing - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Blood Group Typing Market Size, Share & Trends Analysis Report by Product, Techniques, Test Type, Region, and Growth Forecasts, 2026-2033 - Product Image

Blood Group Typing Market Size, Share & Trends Analysis Report by Product, Techniques, Test Type, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Blood Group Typing Market Report 2026 - Product Image

Blood Group Typing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Blood Group Typing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Blood Group Typing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From
Blood Group Typing - A Global Market Overview - Product Image

Blood Group Typing - A Global Market Overview

  • Report
  • 319 Pages
  • Global
From

About the Blood Typing Market

The Blood Typing market within the context of Coagulation and Hemostasis Testing is a specialized field of laboratory testing that focuses on the identification of blood types and the detection of antibodies in the blood. This type of testing is used to diagnose and monitor a variety of conditions, including hemophilia, thrombosis, and other bleeding disorders. It is also used to determine compatibility for blood transfusions and organ transplants. Blood typing is typically performed using a variety of techniques, such as agglutination, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR). The Blood Typing market is a highly competitive field, with a variety of companies offering products and services. Some of the major players in the market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.